Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05261425 · ClinicalTrials.gov registry record · NA
Suture Closure Trial
A NA study of Surgical Wound and Upper Extremity Injury, sponsored by Emory University.
- Active
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 3
- Study locations
NCT05261425: Active NA study of Surgical Wound and Upper Extremity Injury, sponsored by Emory University.
NCT05261425 is a NA study of Surgical Wound and Upper Extremity Injury that is active but no longer recruiting, run by Emory University. The registered enrollment target is 160 participants, above the 86-participant average among 17 other Surgical Wound trials with a reported enrollment target (86% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05261425, a NA study of Surgical Wound and Upper Extremity Injury, is active but no longer recruiting, sponsored by Emory University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 3
- Study locations
Study Summary
Closure of surgical incisions in orthopedic procedures contributes to patient postoperative pain and risk of complication. As the focus on improving orthopedic surgery outcomes shifts to best practices in postoperative pain management, it is important to consider suture types and techniques. This study specifically would focus on comparing different suture types and techniques and their efficacy. This will be a randomized controlled trial comparing currently used, standard of care suture types and currently used, standard of care suture techniques to identify differences, if any exist, in postoperative pain scores and wound healing as assessed by exam and postoperative patient surveys. Patients will be identified by the Emory Upper Extremity/Hand Surgeons as they are identified as a candidate for surgery. Participants will then be informed of the study and spoken to about the specifics of the study. The research team will consent and recruit patients either in The Emory Clinic or in the preoperative area prior to surgery. All surgical operations will take place at the ambulatory surgical center in The Emory Clinic or at the Emory University Orthopaedic and Spine Hospital. Patients will not be compensated for participation in this study. No specimens/data/samples will be collected and stored for later use, and there are no optional substudies. This proposed study will address the lack of published literature regarding the suture technique in hand and wrist surgery in particular. Combined with examining various suture materials, the proposal has the potential to provide a valuable and actionable base of knowledge to the current body of literature.
Primary Outcome
Participants will be asked to complete questionnaires to evaluate their pain at each follow-up visit. The Visual Analog Scale will be the subjective measurement to evaluate changes in pain scores, with values ranging from 0 (no pain) to 10 (very severe pain). A higher score indicates worse pain.
Conditions Studied
Interventions
- DEVICE Monocryl buried
- DEVICE Nylon (FDA Approved) not buried
Study Locations (3)
Georgia
- Emory Orthopedic and Spine Hospital - Atlanta
- Emory Executive Park - Atlanta
- Emory Orthopaedics and Spine Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2024-02-05 |
| Est. Completion | 2026-03 |
| Phase | NA |
What the registry record for NCT05261425 still lists
NCT05261425 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, above the 86-participant average among 17 other Surgical Wound trials with a reported enrollment target (86% higher).
The record links to 2 conditions, with Surgical Wound appearing as the primary indexed condition, and to 2 interventions - of which Monocryl buried is the first listed.
NCT05261425 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05261425 about?
NCT05261425 is a clinical study titled "Suture Closure Trial". Closure of surgical incisions in orthopedic procedures contributes to patient postoperative pain and risk of complication. As the focus on improving orthopedic surgery outcomes shifts to best practices in postoperative pain management, it is important to consider suture types and techniques. This s...
What is the current status of trial NCT05261425?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2024-02-05. Estimated completion is 2026-03.
What conditions does trial NCT05261425 study?
This clinical trial studies the following conditions: Surgical Wound, Upper Extremity Injury.
What interventions are being tested in trial NCT05261425?
The interventions under investigation include: Monocryl buried (DEVICE), Nylon (FDA Approved) not buried (DEVICE).
Who is sponsoring clinical trial NCT05261425?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05261425 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Wound
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05261425's enrollment target sits among peer trials
160 4th of 17 higher than 14 of 17 other Surgical Wound trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgical Wound trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Versus Delayed Bathing of Orthopaedic Surgical Wounds
RECRUITING · NA
-
Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyx™ is Used for Full Thickness Wounds
ACTIVE NOT RECRUITING · NA
-
Influence of Sun Protection and Linear Repair of Cutaneous Surgical Defects
ACTIVE NOT RECRUITING · NA
-
Randomized Controlled Trial to Investigate Clinical Outcomes and Associated Costs When PermeaDerm is Used as Temporary Dressing for Surgical Wounds
ACTIVE NOT RECRUITING · NA
-
RESPECT Trial - (Rapid Extravascular Sealing Via PercutanEous Collagen ImplanT)
COMPLETED · NA
-
Continuous Diffusion of Oxygen Treatment for Incision Wounds
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI